Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients

SAM Dhaese, JA Roberts, M Carlier… - International journal of …, 2018 - Elsevier
Dosing recommendations for continuous infusion of piperacillin, a broad-spectrum beta-
lactam antibiotic, are mainly guided by outputs from population pharmacokinetic models …

Population pharmacokinetics of piperacillin following continuous infusion in critically ill patients and impact of renal function on target attainment

V Klastrup, A Thorsted, M Storgaard… - Antimicrobial agents …, 2020 - Am Soc Microbiol
Pharmacokinetic changes are often seen in patients with severe infections. Administration
by continuous infusion has been suggested to optimize antibiotic exposure and …

[HTML][HTML] Population pharmacokinetics of piperacillin in plasma and subcutaneous tissue in patients on continuous renal replacement therapy

M Bue, T Sou, ASL Okkels, P Hanberg… - International Journal of …, 2020 - Elsevier
Objectives Piperacillin is a β-lactam antimicrobial frequently used in critically ill patients with
acute kidney injury treated with continuous renal replacement therapy (CRRT). However …

Using a validated population pharmacokinetic model for dosing recommendations of continuous infusion piperacillin for critically ill adult patients

I El-Haffaf, R Guilhaumou, L Velly, A Marsot - Clinical Pharmacokinetics, 2022 - Springer
Abstract Background and Objective Piperacillin is a broad-spectrum β-lactam antibiotic
commonly prescribed in intensive care units. Many piperacillin population pharmacokinetic …

First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis

JA Roberts, CMJ Kirkpatrick, MS Roberts… - International journal of …, 2010 - Elsevier
The objectives of this study were (i) to compare the plasma concentration–time profiles for
first-dose and steady-state piperacillin administered by intermittent or continuous dosing to …

Population pharmacokinetics of piperacillin in sepsis patients: should alternative dosing strategies be considered?

MG Andersen, A Thorsted, M Storgaard… - Antimicrobial agents …, 2018 - Am Soc Microbiol
Sufficient antibiotic dosing in septic patients is essential for reducing mortality. Piperacillin-
tazobactam is often used for empirical treatment, but due to the pharmacokinetic (PK) …

Does consistent piperacillin dosing result in consistent therapeutic concentrations in critically ill patients? A longitudinal study over an entire antibiotic course

M Carlier, S Carrette, V Stove, AG Verstraete… - International journal of …, 2014 - Elsevier
Piperacillin plasma concentrations are known to vary between critically ill patients. However,
there are no comprehensive data on the variability of antibiotic concentrations within the …

Pharmacokinetics of an extended 4‐hour infusion of piperacillin‐tazobactam in critically ill patients undergoing continuous renal replacement therapy

DK Awissi, A Beauchamp, E Hébert… - … : The Journal of …, 2015 - Wiley Online Library
Study Objective To evaluate the pharmacokinetic and pharmacodynamic profiles of
piperacillin‐tazobactam administered as a 4‐hour infusion in critically ill patients undergoing …

Population pharmacokinetics and pharmacodynamics of piperacillin in critically ill patients during the early phase of sepsis

W Sukarnjanaset, S Jaruratanasirikul… - … of Pharmacokinetics and …, 2019 - Springer
This study aimed to characterize the population pharmacokinetics (PKs) of piperacillin and
investigate probability of target attainment (PTA) and cumulative fraction of response (CFR) …

Population pharmacokinetics of piperacillin at two dose levels: influence of nonlinear pharmacokinetics on the pharmacodynamic profile

CB Landersdorfer, JB Bulitta… - Antimicrobial agents …, 2012 - Am Soc Microbiol
Piperacillin in combination with tazobactam is one of the most commonly used intravenous
antibiotics. There is evidence for a possible saturable elimination of piperacillin. Therefore …